To confirm that CD8+ T cell infiltration mediates tumor regression after NR2F6 loss, we depleted CD8+ T cells from mice inoculated with NR2F6-deficient B16F10 cells via injection of anti-CD8 neutralizing antibodies (Fig. 3G). This evidence concerns the gene CD8A and neoplasm.